Blood Test Detects 50 Cancers in One Vial

Imagine catching cancer early with a single blood test instead of multiple scans and exams spread across years. That future could arrive as soon as this year.

The FDA is reviewing a blood test called Galleri that can detect traces of up to 50 different cancers from one vial of blood. If approved in 2024, it would mark a fundamental shift in how doctors screen for cancer.

Right now, Americans commonly screen for just five cancers: breast, colon, cervical, prostate, and lung. Each requires its own separate procedure, from CT scans to Pap smears. The new blood tests can spot cancer markers for ten times as many cancers in a single draw.

"Instead of screening for individual cancers, we can now screen an individual for multiple cancers simultaneously," says Megan Hall, vice president of medical affairs at Grail, the company behind Galleri. Another similar test called Cancerguard by Exact Sciences is also under review.

The tests don't diagnose cancer themselves. Instead, they alert doctors where to look more closely, catching deadly cancers like pancreatic and liver cancer that currently have no routine screening at all.

Congress already voted to allow Medicare coverage for these multi-cancer tests starting in 2028. Right now, the Galleri test costs $950 out of pocket, while Cancerguard runs $659.

Early results from studies involving over 177,000 people show real promise. In the third year of testing, researchers saw a 26% reduction in stage 4 cancers, the hardest to treat. These include pancreatic, liver, lung, and gastric cancers that often go undetected until it's too late.

The technology is already transforming cancer care in other ways. Doctors use similar blood tests to monitor existing cancer patients and choose more effective treatments based on a tumor's specific genetic makeup.

Why This Inspires

Dr. Arif Kamal from the American Cancer Society says the science is sound and the technology is solid. The only question now is how quickly it will reach patients who need it.

What makes this breakthrough especially hopeful is its simplicity. No more coordinating multiple appointments, enduring uncomfortable procedures, or missing screenings because they're too complex or expensive. A single blood draw could save thousands of lives by catching cancers when they're most treatable.

For people who fear cancer or have family histories of the disease, this test offers something precious: the chance to find answers early, when hope matters most.

The future of cancer screening isn't just more effective, it's finally becoming easier for everyone to access.